Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
PHASE1
RATIONALE: Giving chemotherapy before a donor umbilical cord blood stem cel...
Status
Unknown
Location
Penn State Cancer Institute at Milton S. Hershey Medical Center
Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
PHASE2
RATIONALE: Giving low doses of chemotherapy and total-body irradiation befo...
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
NA
RATIONALE: Giving low doses of chemotherapy, such as cyclophosphamide and f...